Ambeed.cn

首页 / 抑制剂/激动剂 / 膜转运蛋白 / 钾通道 / ICA-27243

ICA-27243 {[allProObj[0].p_purity_real_show]}

货号:A458603

ICA-27243是一种选择性 KCNQ2/Q3 钾通道开放剂,用于研究癫痫和神经系统疾病的治疗。

ICA-27243 化学结构 CAS号:325457-89-4
ICA-27243 化学结构
CAS号:325457-89-4
ICA-27243 3D分子结构
CAS号:325457-89-4
ICA-27243 化学结构 CAS号:325457-89-4
ICA-27243 3D分子结构 CAS号:325457-89-4
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

ICA-27243 纯度/质量文件 产品仅供科研

货号:A458603 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Potassium Channel 其他靶点 纯度
Tolbutamide 98%
Glimepiride ++++

SUR2B, IC50: 7.3 nM

SUR1, IC50: 5.4 nM

97%
Dronedarone HCl 95%
Gliquidone ++

Potassium channel, IC50: 27.2 nM

99%
TRAM-34 +++

IKCa1 (KCa3.1), Kd: 20 nM

98%
Glibenclamide 98%
Amiodarone HCl 97%
Gliclazide ++

Potassium channel, IC50: 184 nM

98%
Repaglinide 98%
Dofetilide 98%
Nateglinide 99%
Quinine HCl dihydrate 98%
ML133 HCl +

Kir2.1, IC50: 290 nM

99%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

ICA-27243 生物活性

描述 ICA-27243 is a selective, potent and orally active KCNQ2/Q3 potassium channel opener with an EC50 value of 0.38 μM. ICA-27243 is less effective in activating KCNQ4 and KCNQ3/Q5. ICA-27243 exhibits antiepileptic and anticonvulsant effects[1][2]. In SH-SY5Y human neuroblastoma cells, ICA-27243 produces membrane potential hyperpolarisation, which is prevented in combination with the M-current inhibitors XE-991 and Linopirdine. In CHO cells stably expressing heterotrimeric KCNQ2/Q3 channels, ICA-27243 enhanced 86Rb+ efflux (EC50=0.2 μM) and whole-cell currents (EC50=0.4 μM). Activation of KCNQ2/Q3 channels was associated with a voltage-dependent hyperpolarising shift in channel activation (V1/2 shifted to -19 mV at 10 μM)[1].

ICA-27243 细胞实验

Cell Line
Concentration Treated Time Description References
dorsal root ganglion neurons 10 µM 8 days To evaluate the effect of ICA-27243 on axonal growth of dorsal root ganglion neurons, results showed that ICA-27243 tended to decrease axonal elongation. Int J Mol Sci. 2024 Jul 3;25(13):7327
dorsal root ganglion neurons 10 µM 4 days To evaluate the effect of ICA-27243 on axonal growth of dorsal root ganglion neurons, results showed that ICA-27243 tended to decrease axonal elongation. Int J Mol Sci. 2024 Jul 3;25(13):7327
F11 cells 3 μM 7–8 min ICA-27243 inhibited CAP-induced [Ca2+]i increases, with effects similar to RTG Int J Mol Sci. 2019 Sep 4;20(18):4322
F11 cells 1–20 μM 7–8 min ICA-27243 dose-dependently inhibited BK-induced [Ca2+]i increases, with a maximal inhibition of ~60% and an IC50 of ~5 μM Int J Mol Sci. 2019 Sep 4;20(18):4322
Cryopreserved dorsal root ganglion neurons 10 μM 10 seconds To test the hyperpolarization effect of ICA-27243 on cryopreserved dorsal root ganglion neurons, results showed cryopreservation did not affect the hyperpolarization effect of ICA-27243. Mol Pain. 2018 Jan-Dec;14:1744806917749669
Dorsal root ganglion neurons (Wistar rats) 10 μM 10 seconds To test the hyperpolarization effect of ICA-27243 on dorsal root ganglion neurons from Wistar rats, results showed a weaker hyperpolarization effect of ICA-27243. Mol Pain. 2018 Jan-Dec;14:1744806917749669
Dorsal root ganglion neurons (SD rats) 10 μM 10 seconds To test the hyperpolarization effect of ICA-27243 on dorsal root ganglion neurons from SD rats, results showed ICA-27243 significantly hyperpolarized the neuronal membrane potential. Mol Pain. 2018 Jan-Dec;14:1744806917749669
spinal cord organotypic cultures (SCOCs) 10 μM 30 min prevented MN degeneration under acute excitotoxic conditions Neurotherapeutics. 2024 Mar;21(2):e00319

ICA-27243 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Transgenic SOD1G93A mice ALS transgenic mouse model Intraperitoneal injection 10 mg/kg/day Daily administration until the end of the experiment Improved neuromuscular function, maintained motor coordination, reduced spinal motor neuron death and glial reactivity Neurotherapeutics. 2024 Mar;21(2):e00319
Rats Spontaneously hypertensive rats (SHR) and normotensive rats (WKY) Intravenous injection 11.2 µmol/kg Single dose, observed for 15 minutes ICA-27243 increased tyramine-stimulated norepinephrine overflow and epinephrine secretion in female SHR and reduced the TPR-response to tyramine in female SHR. Front Physiol. 2018 Feb 20;9:117

ICA-27243 动物研究

Animal study Administered orally at doses of 1-100 mg/kg, ICA-27243 exhibits anticonvulsant activity in a mouse model of maximal electroshock epilepsy with an ED50 value of 8.4 mg/kg[1].

ICA-27243 参考文献

[1]Wickenden AD, et al. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Mol Pharmacol. 2008 Mar;73(3):977-86.

[2]Amato G, et al. N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy. ACS Med Chem Lett. 2011 Mar 31;2(6):481-4.

ICA-27243 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.72mL

0.74mL

0.37mL

18.61mL

3.72mL

1.86mL

37.22mL

7.44mL

3.72mL

ICA-27243 技术信息

CAS号325457-89-4
分子式C12H7ClF2N2O
分子量 268.65
SMILES Code O=C(NC1=CC=C(Cl)N=C1)C2=CC=C(F)C(F)=C2
MDL No. MFCD17166959
别名
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, 2-8°C

溶解方案

DMSO: 250 mg/mL(930.59 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。